Celltrion Healthcare Ranks High in Searches... Stock Price Down 2.03%
As of 2:31 PM on the 1st, Celltrion Healthcare is trading at 106,200 KRW, down 2.03% from the previous day. This represents a 15.06% increase compared to June 3rd. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have a net purchase of 12,082 shares of Celltrion Healthcare, while institutions have a net sale of 5,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 666,528 shares, while foreigners and institutions have net sold 225,625 shares and 507,925 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- "I Went to 10 Convenience Stores and Still Couldn't Buy It": The Bread Sensation That Sold 100 Million Units Already [The Way We Shop Now]
- Trump Pressures Taiwan to Relocate Semiconductor Industry to U.S., Says "Taiwan Took Away America's Semiconductor Industry"
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
